NCT07194083 Effectiveness- Implementation Trial of the Function-Based Elopement Treatment
| NCT ID | NCT07194083 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-03-30 |
| Primary Completion | 2028-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-03-30 with a primary completion date of 2028-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test whether the Function-Based Elopement Treatment (FBET) can reduce elopement in children aged 4-12 with autism spectrum disorder (ASD), and to assess its feasibility in community-based Applied Behavior Analysis (ABA) clinics. Researchers will evaluate FBET in a single-arm open-label trial in one clinic, followed by a comparison of FBET to treatment as usual (TAU) across at least six ABA clinics to evaluate effectiveness and implementation. The main questions it aims to answer are: * Is it feasible to use FBET in community-based ABA clinics? * Does FBET reduce elopement? * Does FBET lead to greater clinical improvement? Participants will: * Receive 12 sessions of FBET over 20 weeks with trained BCBAs or receive treatment as usual * Complete caregiver assessments at baseline and endpoint * Engage in caregiver training and practice treatment between appointments
Eligibility Criteria
Inclusion Criteria: Child participant: * Boys and girls ages \> 4 to \< 12 years * Autism Spectrum Disorder (ASD) diagnosis by history * Presence of elopement as an important caregiver concern - elopement occurring regularly for at least 3 months. * At least one primary caregiver can speak and understand English. Exclusion Criteria: • Non-English speaking participants
Contact & Investigator
Mindy Scheithauer
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT07194083 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 12 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07194083 currently recruiting?
Yes, NCT07194083 is actively recruiting participants. Contact the research team at Mindy.Scheithauer@choa.org for enrollment information.
Where is the NCT07194083 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT07194083 clinical trial?
NCT07194083 is sponsored by Emory University. The principal investigator is Mindy Scheithauer at Emory University. The trial plans to enroll 50 participants.